Upregulation of the inhibitory receptor ILT4 in monocytes from septic patients

Human Immunology

Volumn 74, Issue 10, 2013, Pages 1244-1250

  Baffari, Eleonora ^a   Fiume, Diego ^a   Caiazzo, Giordana ^a   Sinistro, Anna ^a   Natoli, Silvia ^a   Almerighi, Cristiana ^a   Calò Carducci, Francesca ^b   Leonardis, Francesca ^a   Bergamini, Alberto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

APC; FITC; ILT4; LPS; PBMC; PC5; PE; SAPS II; SOFA

Indexed keywords

CD86 ANTIGEN; ENDOTOXIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIKE TRANSCRIPT 4; INTERLEUKIN 10; INTERLEUKIN 12; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIMULUS LYSATE TEST; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; UPREGULATION;

ANTIGEN PRESENTING CELL; APC; FITC; FLUORESCEIN ISOTHIOCYANATE; ILT4; IMMUNOGLOBULIN LIKE TRANSCRIPT 4; LIPOPOLYSACCHARIDE; LPS; PBMC; PC5; PE; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHYCOERYTHRIN; R-PHYCOERYTHRIN-CYANINE; SAPS II; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SOFA;

AGED; ANTIGENS, CD86; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; RECEPTORS, IMMUNOLOGIC; SEPSIS; UP-REGULATION;

EID: 84883774254     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.07.012     Document Type: Article

References (35)

1. Annane D., Bellissant E., Cavaillon J.M. Septic shock. Lancet 2005, 365:63-78.
2. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
3. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. New Engl J Med 2003, 348:138-150.
4. Faist E., Schinkel C., Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996, 20:454-459.
5. Volk H.D., Reinke P., Docke W.D. Clinical aspects: from systemic inflammation to "immunoparalysis". Chem Immunol 2000, 74:162-177.
6. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002, 28:108-121.
7. Ylipalosaari P., Ala-Kokko T.I., Laurila J., Ohtonen P., Syrjala H. Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study. Crit Care 2006, 10:R66.
8. Wang T.S., Deng J.C. Molecular and cellular aspects of sepsis-induced immunosuppression. J Mol Med 2008, 86:495-506.
9. Monneret G., Lepape A., Voirin N., Bohé J., Venet F., Debard A.L., et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006, 32:1175-1183.
10. Fumeaux T., Dufour J., Stern S., Pugin J. Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med 2004, 30:2028-2037.
11. Brunialti M.K., Martins P.S., Barbosa de Carvalho H., Machado F.R., Barbosa L.M., et al. TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 2006, 25:351-357.
12. Oberholzer A., Oberholzer C., Moldawer L.L. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001, 16:83-96.
13. Boomer J.S., Shuherk-Shaffer J., Hotchkiss R.S., Green J.M. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care 2012, 16:R112.
14. von Müller L., Klemm A., Weiss M., Schneider M., Suger-Wiedeck H., Durmus N., et al. Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 2006, 12:1517-1522.
15. - T cells. Int Immunol 1998, 10:775-783.
16. Vlad G., Piazza F., Colovai A., Cortesini R., Della Pietra F, Suciu-Foca N, et al. Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. Hum Immunol 2003, 64:483-489.
17. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002, 3:237-243.
18. Miyazaki T., Wolf P., Tourne S., Waltzinger C., Dierich A., Barois N., et al. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 1996, 84:531-541.
19. Placido R., Mancino G., Amendola A., Vendetti S., Piacentini M., Sanduzzi A., et al. Apoptosis of human monocytes/macrophages in mycobacterium tuberculosis infection. J Pathol 1997, 181:31-38.
20. Venet F., Chung C.S., Kherouf H., Geeraert A., Malcus C., Poitevin F., et al. Increased circulating regulatory T cells (CD4(+)CD25(+)CD127(-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009, 35:678-686.
21. Wolk K., Docke W.-D., von Baehr V., Volk H.-D., Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000, 96:218-233.
22. Newton S., Ding Y., Chung C.-S., Chen Y., Lomas-Neira J.L., Ayala A. Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response. Surg Infect (Larchmt) 2004, 5:375-383.
23. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353.
24. Burchardi H., Schneider H. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy. Pharmacoeconomics 2004, 22:793-813.
25. Doyle J.S., Buising K.L., Thursky K.A., Worth L.J., Richards M.J. Epidemiology of infections acquired in intensive care units. Semin Respir Crit Care Med 2011, 32:115-138.
26. Graebin P., Veit T.D., Alho C.S., Dias F.S., Chies J.A.B. Polymorphic variants in exon 8 at the 3' UTR of the HLA-G gene are associated with septic shock in critically ill patients. Crit Care 2012, 16:R211.
27. Monneret G., Voirin N., Krawice-Radanne I., Bohé J., Lepape A., Rouas-Freiss N., et al. Soluble human leukocyte antigen-G5 in septic shock: marked and persisting elevation as a predictor of survival. Crit Care Med 2007, 35:1942-1947.
28. Sfeir T., Saha D.C., Astiz M., Rackow E.C. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 2001, 29:129-133.
29. Wu H.P., Shih C.C., Lin C.Y., Hua C.C., Chuang D.Y. Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivors. Crit Care 2011, 15:R224.
30. Manjuck J., Saha D.C., Astiz M., Eales L.J., Rackow E.C. Decreased response to recall antigens is associated with depressed costimulatory receptor in septic critically ill patients. J Lab Clin Med 2000, 135:153-160.
31. Newton S., Ding Y., Chung C.-S., Chen Y., Lomasneira J.L., Ayala A. Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response. Surg Infect (Larchmt) 2004, 5:375-383.
32. Zimmer A., Bouley J., Le Mignon M., Pliquet E., Horiot S., Turfkruyer M., et al. A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy. J Allergy Clin Immunol 2012, 129:1020-1030.
33. Cao S., Liu J., Chesi M., Bergsagel P.L., Ho I.C., Donnelly R.P., et al. Ma X Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J Immunol 2002, 169:5715-5725.
34. Monneret G., Finck M.E., Venet F., Debard A.L., Bohé J., Bienvenu J., et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 2004, 95:193-198.
35. Gogos C.A., Drosou E., Bassaris H.P., Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000, 181:176-180.